Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141843 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141844 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141845 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141846 |
| CAS No | NA |
| Mol.F. | C24H19N7O4 |
| Mol.Wt. | 469.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141847 |
| CAS No | NA |
| Mol.F. | C23H18N4O5 |
| Mol.Wt. | 430.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141848 |
| CAS No | NA |
| Mol.F. | C32H42F6N12O15P2S4 |
| Mol.Wt. | 1138.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141849 |
| CAS No | NA |
| Mol.F. | C16H21F3N6O5S2 |
| Mol.Wt. | 498.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141850 |
| CAS No | NA |
| Mol.F. | C11H13F3N6O2S2 |
| Mol.Wt. | 382.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141851 |
| CAS No | NA |
| Mol.F. | C11H12F3N7O3S2 |
| Mol.Wt. | 411.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141852 |
| CAS No | NA |
| Mol.F. | C16H22F3N6O8PS2 |
| Mol.Wt. | 578.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141853 |
| CAS No | NA |
| Mol.F. | C11H13F3N6OS2 |
| Mol.Wt. | 366.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141854 |
| CAS No | NA |
| Mol.F. | C11H12F3N7O2S2 |
| Mol.Wt. | 395.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141855 |
| CAS No | NA |
| Mol.F. | C16H19F3N6Na2O10P2S2 |
| Mol.Wt. | 684.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141856 |
| CAS No | NA |
| Mol.F. | C32H43F6N11O14P2S4 |
| Mol.Wt. | 1109.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141857 |
| CAS No | NA |
| Mol.F. | C17H20Cl2F3N6O14P3S2 : 4(Na) |
| Mol.Wt. | 817.3 : 4(23.0) |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141858 |
| CAS No | NA |
| Mol.F. | C17H24Cl2F3N6O13P3S2 |
| Mol.Wt. | 805.3 |
| INV STATUS | CUSTOM SYNTHESIS |